Technical Analysis for MDP - Medexus Pharmaceuticals Inc.

Grade Last Price % Change Price Change
F 1.550 2.65% 0.040
MDP closed up 2.65 percent on Thursday, April 18, 2024, on approximately normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
0 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down

Date Alert Name Type % Chg
Bullish Engulfing Bullish 0.00%
Bollinger Band Squeeze Range Contraction 0.00%
BB Squeeze + Lower Band Touch Range Contraction 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Oversold Stochastic Weakness 0.00%
Bollinger Band Squeeze Range Contraction 2.65%
NR7 Range Contraction 2.65%
Stochastic Reached Oversold Weakness 2.65%
Down 3 Days in a Row Weakness 2.65%
Oversold Stochastic Weakness 2.65%

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Medexus Pharmaceuticals Inc. Description

Medexus Pharmaceuticals Inc, formerly Pediapharm Inc, is a Canada-based company engaged in pharmaceutical business sector. The Company is a North American focused, specialty pharmaceutical business that operates through three segments: Medac Pharma USA, a fully integrated commercial infrastructure focused on auto-immune diseases in the United States; Medexus Pharma Canada, a fully integrated commercial infrastructure focused on auto-immune disease and pediatric diseases in Canada; and a Business Development function, which works to maintain its product pipeline. The Company's flag products are Rasuvo and Metoject, a formulation of methotrexate (auto-pen and pre-filled syringe) designed to treat rheumatoid arthritis and other auto-immune diseases; and Rupall, an allergy medication. The Company provides products for the healthcare professionals and patients.


Classification

Keywords: Health Infrastructure Healthcare Pharma Pipe Pharmaceutical Integrated Pipeline Disease Drugs Pharmaceuticals Diseases Arthritis Medication Cnx Nifty Pharmaceutical Business Sector Pharmaceutical Industry In China Rheumatoid Arthritis

Is MDP a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 3.53
52 Week Low 1.12
Average Volume 55,112
200-Day Moving Average 2.211
50-Day Moving Average 1.678
20-Day Moving Average 1.586
10-Day Moving Average 1.562
Average True Range 0.096
RSI (14) 43.50
ADX 14.43
+DI 13.424
-DI 20.418
Chandelier Exit (Long, 3 ATRs) 1.471
Chandelier Exit (Short, 3 ATRs) 1.759
Upper Bollinger Bands 1.698
Lower Bollinger Band 1.474
Percent B (%b) 0.34
BandWidth 14.136
MACD Line -0.046
MACD Signal Line -0.051
MACD Histogram 0.0051
Fundamentals Value
Market Cap 22.4 Million
Num Shares 14.5 Million
EPS -0.66
Price-to-Earnings (P/E) Ratio -2.36
Price-to-Sales 0.84
Price-to-Book 3.19
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.670
Resistance 3 (R3) 1.657 1.603 1.650
Resistance 2 (R2) 1.603 1.573 1.610 1.643
Resistance 1 (R1) 1.577 1.554 1.590 1.590 1.637
Pivot Point 1.523 1.523 1.530 1.530 1.523
Support 1 (S1) 1.497 1.493 1.510 1.510 1.463
Support 2 (S2) 1.443 1.474 1.450 1.457
Support 3 (S3) 1.417 1.443 1.450
Support 4 (S4) 1.430